KALA - Kala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALA is currently covered by 2 analysts

Kala Pharmaceuticals's activity chart (see below) currently has 29 price targets and 28 ratings on display. The stock rating distribution of KALA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.53% with an average time for these price targets to be met of 93.83 days.

Highest price target for KALA is $17, Lowest price target is $17.

Most recent stock forecast was given by from HC WAINWRIGHT on 17-Sep-2025. First documented stock forecast 13-Aug-2017.

Currently out of the existing stock ratings of KALA, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Mar-2023

$35

$32.48 (1288.89%)

$12

1 years 20 days ago
(17-Sep-2025)

7/15 (46.67%)

$17.53 (100.34%)

232

Buy Since 11-Sep-2025

$33

$30.48 (1209.52%)

1 years 26 days ago
(11-Sep-2025)

0/1 (0%)

$16 (94.12%)

Buy Since 01-Jun-2020

$15

$12.48 (495.24%)

$15

1 years 5 months 23 days ago
(14-Apr-2025)

5/6 (83.33%)

$11.51 (329.80%)

307

Buy

4 years 1 months 22 days ago
(14-Aug-2022)

0/2 (0%)

$390 (108.33%)

Sell

$75

$73.69 (5625.19%)

4 years 6 months 7 days ago
(29-Mar-2022)

0/2 (0%)

$2 (2.74%)

Show more analysts

Please expand the browser size to see the chart

What is KALA (Kala Pharmaceuticals) average time for price targets to be met?

On average it took 94 days for the stock forecasts to be reached, with an average price target met ratio of 26.53%.

Which analyst most recently updated their price target on KALA (Kala Pharmaceuticals)?

Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?

has 0 price targets and 0 ratings on KALA

Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?

David Maris with the highest potential upside of $948.69

Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?

Chris Schott with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?